Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P4YV | ISIN: US7291391057 | Ticker-Symbol: 9PT
Tradegate
27.03.24
19:30 Uhr
13,500 Euro
-0,300
-2,17 %
1-Jahres-Chart
PLIANT THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PLIANT THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
13,60014,00028.03.
13,70013,90028.03.

Aktuelle News zur PLIANT THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPliant Therapeutics, Inc.: Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference1
22.03.MASI, PLRX and CGC are among after hour movers1
19.03.Pliant Technologies to Debut Crewware 2.0 Software Update at 2024 NAB Show-
12.03.EU nod advances Pliant's lung disease drug trial1
12.03.PLIANT THERAPEUTICS, INC. - 8-K, Current Report1
12.03.Pliant Therapeutics, Inc.: Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis691Acceptance by European Union and other global health authorities of the pivotal, adaptivePhase 2b/3 trial will significantly shorten bexotegrast's time to Phase 3 data Upsized Oxford Finance debt...
► Artikel lesen
07.03.Pliant Technologies to Show New Mini In-Ear Headset, Accessories at NAB Show-
05.03.RBC raises Pliant Therapeutics stock target to $54 on IPF drug potential1
27.02.PLIANT THERAPEUTICS, INC. - S-8, Securities to be offered to employees in employee benefit plans1
27.02.PLIANT THERAPEUTICS, INC. - 10-K, Annual Report-
27.02.PLIANT THERAPEUTICS, INC. - 8-K, Current Report2
13.02.Pliant Technologies Expands Sales Network1
05.02.Why Is Liver Disease-Focused Pliant Therapeutics Stock Trading Lower Today?4
05.02.Pliant's liver disease treatment slowed progression at highest dose, but efficacy didn't improve stepwise4
05.02.Pliant updates data from mid-stage trial for lead asset1
05.02.PLIANT THERAPEUTICS, INC. - 8-K, Current Report1
04.02.Pliant Therapeutics, Inc.: Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis 205Bexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; No safety concerns identified across all dose cohorts Bexotegrast...
► Artikel lesen
22.01.PLIANT LLC - S-4/A, Registration of securities, business combinations2
22.01.PLIANT INTERNATIONAL, LLC - S-4/A, Registration of securities, business combinations3
16.01.DealMonitor - Ineratec sammelt 118 Millionen ein - Pliant erhält 8 Millionen - Platform Group übernimmt Avocadostore15
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1